SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

Published:2017-07-19 Issue:10 Volume:60 Page:1862-1872
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Tang Huilin,Dai Qi,Shi Weilong,Zhai Suodi,Song Yiqing,Han Jiali

Funder

Indiana University Health–Indiana University School of Medicine Strategic Research Initiative

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s00125-017-4370-8/fulltext.html

Reference82 articles.

1. Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685

2. Mayor S (2016) Cancer risk is higher in years before and shortly after type 2 diabetes diagnosis, study shows. BMJ 354:i3832

3. Klil-Drori AJ, Azoulay L, Pollak MN (2017) Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? Nat Rev Clin Oncol 14:85–99

4. Lutz SZ, Staiger H, Fritsche A, Haring HU (2014) Antihyperglycaemic therapies and cancer risk. Diab Vasc Dis Res 11:371–389

5. Tuccori M, Filion KB, Yin H, Yu OH, Platt RW, Azoulay L (2016) Pioglitazone use and risk of bladder cancer: population based cohort study. BMJ 352:i1541

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers;Metabolism;2024-11

2. Obesity-Associated Colorectal Cancer;International Journal of Molecular Sciences;2024-08-14

3. The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data;Cell Reports Medicine;2024-08

4. Associations between Diabetes Mellitus and Selected Cancers;International Journal of Molecular Sciences;2024-07-08

5. Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry;Revista Española de Cardiología (English Edition);2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3